Biora Therapeutics, Inc. Proceeds from Stock Plans
Biora Therapeutics, Inc. reported Proceeds from Stock Plans of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockPlans · last filed 2024-04-01
- Biora Therapeutics, Inc. proceeds from stock plans for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Biora Therapeutics, Inc. proceeds from stock plans for the quarter ending 2023-09-30 was $0.00.
- Biora Therapeutics, Inc. proceeds from stock plans for the quarter ending 2022-12-31 was $9.00K.
- Biora Therapeutics, Inc. proceeds from stock plans for the quarter ending 2022-09-30 was $0.00.
- Biora Therapeutics, Inc. proceeds from stock plans for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Biora Therapeutics, Inc. proceeds from stock plans for fiscal 2022 was $98.00K.
- Biora Therapeutics, Inc. proceeds from stock plans for fiscal 2021 was $0.00.
| Period end | Proceeds from Stock Plans 3 month | Proceeds from Stock Plans 6 month | Proceeds from Stock Plans 9 month | Proceeds from Stock Plans 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $0.00 10-K · filed 2024-04-01 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 | |||
| 2022-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $9.00K derived: sum of 2 quarters · filed 2024-04-01 | $98.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $89.00K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $89.00K 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 |